Venture Life Group (LON:VLG) Issues Quarterly Earnings Results

Key Points

• Venture Life Group reported a quarterly earnings per share of GBX 0.83 with a net margin of 1.44% and a return on equity of 0.99%.
• The company's stock is currently trading at GBX 55.50, with a twelve-month range between GBX 32 and GBX 66.
• Insider Jerry Randall purchased 50,000 shares of the company's stock, indicating confidence in the firm, which is partially owned by company insiders at 6.77%.

Venture Life Group (LON:VLG - ) posted its quarterly earnings data on Tuesday. The company reported GBX 0.83 earnings per share for the quarter, Digital Look Earnings reports. Venture Life Group had a net margin of 1.44% and a return on equity of 0.99%.

Venture Life Group Trading Up 0.9%

LON VLG opened at GBX 55.50 on Tuesday. Venture Life Group has a twelve month low of GBX 32 and a twelve month high of GBX 66. The company has a debt-to-equity ratio of 28.45, a quick ratio of 1.48 and a current ratio of 2.22. The stock has a market cap of £71.07 million, a price-to-earnings ratio of -22,199.60, a PEG ratio of 5.67 and a beta of 0.30. The firm's 50 day moving average price is GBX 58.59 and its two-hundred day moving average price is GBX 51.52.

Insider Activity

In related news, insider Jerry Randall bought 50,000 shares of the firm's stock in a transaction on Wednesday, July 2nd. The stock was bought at an average price of GBX 59 per share, with a total value of £29,500. 6.77% of the stock is owned by company insiders.

About Venture Life Group

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in the UK, The Netherlands and Italy, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women's intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing. The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.